Compile Data Set for Download or QSAR
Report error Found 10034 Enz. Inhib. hit(s) with Target = 'Gag-Pol polyprotein'
TargetGag-Pol polyprotein [600-1027,R876K]/[600-1155](Human immunodeficiency virus type 1)
Boehringer Ingelheim Pharmaceuticals

LigandPNGBDBM1583(1 l-Cyclopropyl-5,11-dhydro-4-[[(3-phenylpropyl)ox...)
Affinity DatapH: 7.8 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [600-1027,R876K]/[600-1155](Human immunodeficiency virus type 1)
Boehringer Ingelheim Pharmaceuticals

LigandPNGBDBM1586(7-[(benzylsulfanyl)methyl]-2-cyclopropyl-2,4,9,15-...)
Affinity DatapH: 7.8 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [600-1027,R876K]/[600-1155](Human immunodeficiency virus type 1)
Boehringer Ingelheim Pharmaceuticals

LigandPNGBDBM1589(1l-Cyclopropyl-5,1l-dihydro-4-(l-piperidinylmethyl...)
Affinity DatapH: 7.8 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [600-1027,R876K]/[600-1155](Human immunodeficiency virus type 1)
Boehringer Ingelheim Pharmaceuticals

LigandPNGBDBM1592(2-cyclopropyl-7-(1H-imidazol-1-ylmethyl)-2,4,9,15-...)
Affinity DatapH: 7.8 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [600-1027,R876K]/[600-1155](Human immunodeficiency virus type 1)
Boehringer Ingelheim Pharmaceuticals

LigandPNGBDBM1608(2-cyclopropyl-7-[(E)-2-phenylethenyl]-2,4,9,15-tet...)
Affinity DataAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [600-1027,R876K]/[600-1155](Human immunodeficiency virus type 1)
Boehringer Ingelheim Pharmaceuticals

LigandPNGBDBM1609(ethyl (2Z)-3-{2-cyclopropyl-10-oxo-2,4,9,15-tetraa...)
Affinity DataAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [600-1027,R876K]/[600-1155](Human immunodeficiency virus type 1)
Boehringer Ingelheim Pharmaceuticals

LigandPNGBDBM1610((2Z)-3-{2-cyclopropyl-10-oxo-2,4,9,15-tetraazatric...)
Affinity DataAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [600-1027,R876K]/[600-1155](Human immunodeficiency virus type 1)
Boehringer Ingelheim Pharmaceuticals

LigandPNGBDBM1611(2-cyclopropyl-7-(2-phenylethyl)-2,4,9,15-tetraazat...)
Affinity DataAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [600-1027,R876K]/[600-1155](Human immunodeficiency virus type 1)
Boehringer Ingelheim Pharmaceuticals

LigandPNGBDBM1612(ethyl 3-{2-cyclopropyl-10-oxo-2,4,9,15-tetraazatri...)
Affinity DataAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [600-1027,R876K]/[600-1155](Human immunodeficiency virus type 1)
Boehringer Ingelheim Pharmaceuticals

LigandPNGBDBM1613(3-{2-cyclopropyl-10-oxo-2,4,9,15-tetraazatricyclo[...)
Affinity DataAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [600-1027,R876K]/[600-1155](Human immunodeficiency virus type 1)
Boehringer Ingelheim Pharmaceuticals

LigandPNGBDBM1614(7-benzyl-2-ethyl-5-methoxy-2,4,9,15-tetraazatricyc...)
Affinity DataAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [600-1027,R876K]/[600-1155](Human immunodeficiency virus type 1)
Boehringer Ingelheim Pharmaceuticals

LigandPNGBDBM1622(7-(1,3-dioxan-2-yl)-2-ethyl-5-hydroxy-2,4,9,15-tet...)
Affinity DataAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [600-1027,R876K]/[600-1155](Human immunodeficiency virus type 1)
Boehringer Ingelheim Pharmaceuticals

LigandPNGBDBM1623(5,ll-Dihydro- l l sthyl-4-formyl-2-hydroxy-6H-dipy...)
Affinity DataAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [600-1027,R876K]/[600-1155](Human immunodeficiency virus type 1)
Boehringer Ingelheim Pharmaceuticals

LigandPNGBDBM1625(2-ethyl-5-hydroxy-7-(phenoxymethyl)-2,4,9,15-tetra...)
Affinity DataAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [600-1027,R876K]/[600-1155](Human immunodeficiency virus type 1)
Boehringer Ingelheim Pharmaceuticals

LigandPNGBDBM1626(7-benzyl-2-ethyl-5-(3-methoxyphenyl)-2,4,9,15-tetr...)
Affinity DataAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [600-1027,R876K]/[600-1155](Human immunodeficiency virus type 1)
Boehringer Ingelheim Pharmaceuticals

LigandPNGBDBM1627(4-[(Benzy1oxy)methyll-5,1-dihydro-11-ethyl-2-(3-me...)
Affinity DataAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [600-1027,R876K]/[600-1155](Human immunodeficiency virus type 1)
Boehringer Ingelheim Pharmaceuticals

LigandPNGBDBM1628(5,11-Dihydro-4-[2-(1,3-dioxanyl)]-ll-ethyl-2-(3-me...)
Affinity DataAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [600-1027,R876K]/[600-1155](Human immunodeficiency virus type 1)
Boehringer Ingelheim Pharmaceuticals

LigandPNGBDBM1630(2-ethyl-7-(hydroxymethyl)-5-(3-methoxyphenyl)-2,4,...)
Affinity DataAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [588-1027,P823L]/[588-1147,P823L](Human immunodeficiency virus type 1)
Upjohn

LigandPNGBDBM1948(3-methyl-1-{2-[(4-{methyl[3-(propan-2-ylamino)pyri...)
Affinity DataAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [600-1027,Y787L]/[600-1155,Y787L](Human immunodeficiency virus type 1)
Boehringer Ingelheim Pharmaceuticals

LigandPNGBDBM2016(5,11-Dihydro-11-ethyl-2-(5-fluoroindol-3-yl)-5-met...)
Affinity DatapH: 7.8 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [600-1027,R876K]/[600-1155](Human immunodeficiency virus type 1)
Boehringer Ingelheim Pharmaceuticals

LigandPNGBDBM2017(2-ethyl-9-methyl-5-{1H-pyrrolo[3,2-b]pyridin-3-yl}...)
Affinity DatapH: 7.8 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [600-1027,Y780C]/[600-1155,Y780C](Human immunodeficiency virus type 1)
Boehringer Ingelheim Pharmaceuticals

LigandPNGBDBM2017(2-ethyl-9-methyl-5-{1H-pyrrolo[3,2-b]pyridin-3-yl}...)
Affinity DatapH: 7.8 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [600-1027,Y787L]/[600-1155,Y787L](Human immunodeficiency virus type 1)
Boehringer Ingelheim Pharmaceuticals

LigandPNGBDBM2017(2-ethyl-9-methyl-5-{1H-pyrrolo[3,2-b]pyridin-3-yl}...)
Affinity DatapH: 7.8 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [600-1027,Y787L]/[600-1155,Y787L](Human immunodeficiency virus type 1)
Boehringer Ingelheim Pharmaceuticals

LigandPNGBDBM2018(2-ethyl-9-methyl-5-{1H-pyrrolo[3,2-c]pyridin-3-yl}...)
Affinity DatapH: 7.8 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [588-1027]/[588-1147](Human immunodeficiency virus type 1)
Sapienza University of Rome

LigandPNGBDBM2379(S-DABO | 6-[(2,6-dichlorophenyl)methyl]-5-methyl-2...)
Affinity DataAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/23/2004
Entry Details Article
PubMed
TargetGag-Pol polyprotein [588-1027]/[588-1147](Human immunodeficiency virus type 1)
Sapienza University of Rome

LigandPNGBDBM2932(6-chloro-4-(2-cyclopropylethynyl)-8-methoxy-4-(tri...)
Affinity DatapH: 8.2 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2005
Entry Details Article
PubMed
TargetGag-Pol polyprotein [588-1027]/[588-1147](Human immunodeficiency virus type 1)
Sapienza University of Rome

LigandPNGBDBM2935(6-chloro-4-(2-cyclopropylethynyl)-8-fluoro-4-(trif...)
Affinity DatapH: 8.2 T: 2°CAssay Description:The IC50 of reverse transcriptase is the concentration that inhibits 50% of recombinant HIV-1 RT RNA-directed DNA polymerase activity in vitro.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/4/2005
Entry Details Article
PubMed
TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293264(US10106504, Example 1)
Affinity DataEC50: >1.00E+3nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293264(US10106504, Example 1)
Affinity DataEC50:  1.74E+3nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293265(US10106504, Example 2)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293265(US10106504, Example 2)
Affinity DataEC50:  73nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293266(US10106504, Example 3)
Affinity DataEC50:  550nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293266(US10106504, Example 3)
Affinity DataEC50:  196nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293267(US10106504, Example 4)
Affinity DataEC50:  550nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293268(US10106504, Example 5)
Affinity DataEC50:  550nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293269(US10106504, Example 6)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293270(US10106504, Example 7)
Affinity DataEC50:  550nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293270(US10106504, Example 7)
Affinity DataEC50:  545nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293271(US10106504, Example 8)
Affinity DataEC50:  550nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293272(US10106504, Example 9)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293273(US10106504, Example 10)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293274(US10106504, Example 11)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293275(US10106504, Example 12)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293275(US10106504, Example 12)
Affinity DataEC50:  7nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293276(US10106504, Example 13)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293277(US10106504, Example 14)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293278(US10106504, Example 15)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293279(US10106504, Example 16)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293280(US10106504, Example 17)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

TargetGag-Pol polyprotein [489-587,Q496K](Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandPNGBDBM293281(US10106504, Example 18)
Affinity DataEC50: <100nMpH: 7.55Assay Description:A recombinant NL-RLuc proviral clone was constructed in which a section of the nef gene from NL4-3 was replaced with the Renilla Luciferase gene. Thi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
US Patent

Displayed 1 to 50 (of 10034 total ) | Next | Last >>
Jump to: